Exit Strategies for Startups

June 21, 2022 @ 7:00 pm – 8:30 pm America/New York Timezone

Entrepreneurs’ Network


This event is free of charge.  However, prior registration is required to attend.

ENET Members will also have the opportunity to view a recording of this webinar if you are unable to attend or wish to view it again.   

Free Webinar

Register at https://bostonenet.org/events/exit-strategies-for-startups/#registration-form

You are one of them…a dedicated entrepreneur, who has poured heart and sweat into the venture.   Does this focused dedication to launch and grow the business also include planning for potential future exits?

An exit strategy is an important “early on“ element of the overall business strategy that describes the vision of how you will eventually capitalize on your investment.  The decisions about how you structure and operate the business can have huge implications down the road.

Hear from expert panelists, who have prepared companies in successful exits!    They will talk about exit strategy planning and, just as important, what exits look and feel like in real life to Serial Entrepreneurs, Financial and legal M& A advisors.

Event Schedule

7:00PM –  Introduction, ENET Chairperson’s announcements

7:10PM – eMinute Pitch, up to 3 Startup pitches

7:25PM – Expert Panel, 4 expert speakers on the night’s topic

8:10PM – Q & A Moderator and Audience Q & A with the speakers

8:30PM – Networking, panelists available for responses to individual questions.


Sal Rafanelli, RPh, President and CEO,  Speranza Therapeutics

For the past 27 years, Sal J. Rafanelli, RPh, has built a career on his passion for providing excellent patient care and creating innovative companies.  He is Currently CEO Speranzo Therapeutics, equity partner in Biomatrix and active Board Member.

Previously Sal was a founding member of an infusion company called American Disease Management Associates (ADIMA), that was purchased by BioScrip in August 2000.  He also founded BiologicTx® with his two partners, Darrin Carrico and Todd Krasinsky, RN, and assumed the role as CEO. BiologicTx merged with a company called Matrix to create BioMatrix, which was purchased by a private equity company.

Mr. Rafanelli has a bachelor’s degree from the Massachusetts College of Pharmacy and Allied Health Sciences in Boston, Massachusetts, as well as University of Illinois at Chicago Pharm D program.

Nishta Rao, Managing Director-Life Sciences, First Republic Bank

Nishta is currently Managing Director at First Republic Bank where she is responsible for the growth and expansion of the Bank’s Life Science vertical.

Prior to this, Nishta was Managing Director, BioLabs@NYULangone where she supported the translation of technologies into commercially viable products and therapies. She launched and led Princeton Innovation Center BioLabs (PICb),  was Sr. Director of Scientific Operations at Kadmon, and worked at Mt. Sinai Innovation Partners, tech transfer office.

Nishta speaks at a range of conferences and panels in the life science and healthcare space and serves as a mentor to academic and industry entrepreneurial groups such as Mount Sinai, Weill Cornell eLab programs, BioNJ Bio-Partnering, among others.

Aaron Baral, Senior Associate, Shipman & Goodwin LLP’s Corporate Practice Group.

Aaron Baral is a senior associate in Shipman & Goodwin LLP’s Corporate Practice Group, where he has a broad transactional practice.  Working closely with founders, CEOs, boards of directors and investors, Aaron counsels clients in a broad range of matters, from formation transactions to general commercial contracting and governance, to financings and mergers and acquisitions.

Aaron is a graduate of the UConn School of Law and received his undergraduate degree in Accounting from the UConn School of Business

Don Tucker, CEO and President, Neurosom; Sr. Scientist BEL Company.

Don M. Tucker is CEO and Senior Scientist of The Brain Electrophysiology Laboratory Company and a new startup for electric sleep therapy, Neurosom. He is Emeritus Professor of Psychology at the University of Oregon.

His former company, Electrical Geodesics, Inc., was sold to Philips in 2017. He has published Mind From Body (2007), Cognition and Neural Development with Phan Luu (2012), and Out of the Cave: A Natural Philosophy of Mind and Knowing with Mark Johnson (2021). The medical device became the basis of Electrical Geodesics Inc., which was acquired by the European healthcare company Philips in 2017 for $36.7 million.

Organizers and Moderator:

Kristin King, MBA. BHA Investor; VP, Corporate Development, Defibtech Nihon Kohden.

Kristin is an accomplished MedTech executive, serial intrapreneur, investor and strategic advisor to startups developing biotech solutions.  With over 20 years spanning technical, marketing, and proud member of Boston Harbor Angels, she offers multi-discipline expertise transforming technologies from early concept to successful global divisions at leading Medical Device companies and startups.

Vicki Anastasi, Medical Device Executive & Strategic Advisor

Vicki Anastasi has over 30 years of experience in the medical device industry, with over 20 years specifically focused on global medical device and diagnostic strategic consulting.  She has held senior management roles for medical device and therapeutic companies focused in orthopedics, cardiovascular/metabolic disease and combination products. In diagnostics, she held senior positions at companies involved in the development of infectious disease and genetic-based products including companion diagnostics and precision